Attitudes towards subsequent entry biologics/biosimilars: A survey of Canadian rheumatologists

Overview of attention for article published in Clinical Rheumatology, January 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 13,142 followers.

Attitudes towards subsequent entry biologics/biosimilars: Survey of CDN rheumatologists. http://t.co/ERbC9tobdC #rheum #hcsmca Deciders?

Check out our recently published biosimilars survey! Thanks @MBiotechProgram & @IMIUofT for the support. http://t.co/CIDlKGxvec

Check out our recently published biosimilars survey! Thanks @MBiotechProgram & @IMIUofT for the support. http://t.co/CIDlKGxvec